Know when to fold ‘em: Polycomb complexes in oncogenic 3D genome regulation

Chromatin is spatially and temporally regulated through a series of orchestrated processes resulting in the formation of 3D chromatin structures such as topologically associating domains (TADs), loops and Polycomb Bodies. These structures are closely linked to transcriptional regulation, with loss o...

Full description

Bibliographic Details
Main Authors: Emma J. Doyle, Lluis Morey, Eric Conway
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcell.2022.986319/full
_version_ 1828437130701963264
author Emma J. Doyle
Lluis Morey
Lluis Morey
Eric Conway
Eric Conway
author_facet Emma J. Doyle
Lluis Morey
Lluis Morey
Eric Conway
Eric Conway
author_sort Emma J. Doyle
collection DOAJ
description Chromatin is spatially and temporally regulated through a series of orchestrated processes resulting in the formation of 3D chromatin structures such as topologically associating domains (TADs), loops and Polycomb Bodies. These structures are closely linked to transcriptional regulation, with loss of control of these processes a frequent feature of cancer and developmental syndromes. One such oncogenic disruption of the 3D genome is through recurrent dysregulation of Polycomb Group Complex (PcG) functions either through genetic mutations, amplification or deletion of genes that encode for PcG proteins. PcG complexes are evolutionarily conserved epigenetic complexes. They are key for early development and are essential transcriptional repressors. PcG complexes include PRC1, PRC2 and PR-DUB which are responsible for the control of the histone modifications H2AK119ub1 and H3K27me3. The spatial distribution of the complexes within the nuclear environment, and their associated modifications have profound effects on the regulation of gene transcription and the 3D genome. Nevertheless, how PcG complexes regulate 3D chromatin organization is still poorly understood. Here we glean insights into the role of PcG complexes in 3D genome regulation and compaction, how these processes go awry during tumorigenesis and the therapeutic implications that result from our insights into these mechanisms.
first_indexed 2024-12-10T19:39:36Z
format Article
id doaj.art-a717e715b7734d5696544481f297bf37
institution Directory Open Access Journal
issn 2296-634X
language English
last_indexed 2024-12-10T19:39:36Z
publishDate 2022-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cell and Developmental Biology
spelling doaj.art-a717e715b7734d5696544481f297bf372022-12-22T01:36:02ZengFrontiers Media S.A.Frontiers in Cell and Developmental Biology2296-634X2022-08-011010.3389/fcell.2022.986319986319Know when to fold ‘em: Polycomb complexes in oncogenic 3D genome regulationEmma J. Doyle0Lluis Morey1Lluis Morey2Eric Conway3Eric Conway4School of Biomolecular and Biomedical Science, Conway Institute, University College Dublin, Dublin, IrelandSylvester Comprehensive Cancer Centre, Miami, FL, United StatesDepartment of Human Genetics, Biomedical Research Building, University of Miami Miller School of Medicine, Miami, FL, United StatesSchool of Biomolecular and Biomedical Science, Conway Institute, University College Dublin, Dublin, IrelandSmurfit Institute of Genetics, Trinity College Dublin, Dublin, IrelandChromatin is spatially and temporally regulated through a series of orchestrated processes resulting in the formation of 3D chromatin structures such as topologically associating domains (TADs), loops and Polycomb Bodies. These structures are closely linked to transcriptional regulation, with loss of control of these processes a frequent feature of cancer and developmental syndromes. One such oncogenic disruption of the 3D genome is through recurrent dysregulation of Polycomb Group Complex (PcG) functions either through genetic mutations, amplification or deletion of genes that encode for PcG proteins. PcG complexes are evolutionarily conserved epigenetic complexes. They are key for early development and are essential transcriptional repressors. PcG complexes include PRC1, PRC2 and PR-DUB which are responsible for the control of the histone modifications H2AK119ub1 and H3K27me3. The spatial distribution of the complexes within the nuclear environment, and their associated modifications have profound effects on the regulation of gene transcription and the 3D genome. Nevertheless, how PcG complexes regulate 3D chromatin organization is still poorly understood. Here we glean insights into the role of PcG complexes in 3D genome regulation and compaction, how these processes go awry during tumorigenesis and the therapeutic implications that result from our insights into these mechanisms.https://www.frontiersin.org/articles/10.3389/fcell.2022.986319/fullPolycombH2AK119ub1H3K27me3chromatin architecturecancercompaction
spellingShingle Emma J. Doyle
Lluis Morey
Lluis Morey
Eric Conway
Eric Conway
Know when to fold ‘em: Polycomb complexes in oncogenic 3D genome regulation
Frontiers in Cell and Developmental Biology
Polycomb
H2AK119ub1
H3K27me3
chromatin architecture
cancer
compaction
title Know when to fold ‘em: Polycomb complexes in oncogenic 3D genome regulation
title_full Know when to fold ‘em: Polycomb complexes in oncogenic 3D genome regulation
title_fullStr Know when to fold ‘em: Polycomb complexes in oncogenic 3D genome regulation
title_full_unstemmed Know when to fold ‘em: Polycomb complexes in oncogenic 3D genome regulation
title_short Know when to fold ‘em: Polycomb complexes in oncogenic 3D genome regulation
title_sort know when to fold em polycomb complexes in oncogenic 3d genome regulation
topic Polycomb
H2AK119ub1
H3K27me3
chromatin architecture
cancer
compaction
url https://www.frontiersin.org/articles/10.3389/fcell.2022.986319/full
work_keys_str_mv AT emmajdoyle knowwhentofoldempolycombcomplexesinoncogenic3dgenomeregulation
AT lluismorey knowwhentofoldempolycombcomplexesinoncogenic3dgenomeregulation
AT lluismorey knowwhentofoldempolycombcomplexesinoncogenic3dgenomeregulation
AT ericconway knowwhentofoldempolycombcomplexesinoncogenic3dgenomeregulation
AT ericconway knowwhentofoldempolycombcomplexesinoncogenic3dgenomeregulation